- Home
- CELU vs DHAI Comparison
CELU vs DHAI Comparison
Compare CELU & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- DHAI
- Stock Information
- Founded
- CELU 2016
- DHAI 2007
- Country
- CELU United States
- DHAI United States
- Employees
- CELU N/A
- DHAI N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- DHAI
- Sector
- CELU Health Care
- DHAI
- Exchange
- CELU Nasdaq
- DHAI NYSE
- Market Cap
- CELU 50.4M
- DHAI 49.1M
- IPO Year
- CELU N/A
- DHAI N/A
- Fundamental
- Price
- CELU $1.68
- DHAI $0.49
- Analyst Decision
- CELU
- DHAI
- Analyst Count
- CELU 0
- DHAI 0
- Target Price
- CELU N/A
- DHAI N/A
- AVG Volume (30 Days)
- CELU 182.6K
- DHAI 310.5K
- Earning Date
- CELU 12-06-2024
- DHAI 02-14-2025
- Dividend Yield
- CELU N/A
- DHAI N/A
- EPS Growth
- CELU N/A
- DHAI N/A
- EPS
- CELU N/A
- DHAI N/A
- Revenue
- CELU $48,200,000.00
- DHAI $69,573,000.00
- Revenue This Year
- CELU N/A
- DHAI N/A
- Revenue Next Year
- CELU $233.89
- DHAI N/A
- P/E Ratio
- CELU N/A
- DHAI N/A
- Revenue Growth
- CELU 225.94
- DHAI 5.40
- 52 Week Low
- CELU $1.30
- DHAI $0.48
- 52 Week High
- CELU $7.97
- DHAI $3.67
- Technical
- Relative Strength Index (RSI)
- CELU 37.21
- DHAI 31.78
- Support Level
- CELU $1.85
- DHAI $0.48
- Resistance Level
- CELU $2.18
- DHAI $0.69
- Average True Range (ATR)
- CELU 0.26
- DHAI 0.09
- MACD
- CELU -0.05
- DHAI -0.00
- Stochastic Oscillator
- CELU 5.46
- DHAI 4.00
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.